COMPARATIVE CLINICAL EFFECTIVENESS OF AZACITIDINE VERSUS DECITABINE FOR THE FRONT LINE TREATMENT OF ELDERLY ACUTE MYELOID LEUKEMIA (AML) PATIENTS

被引:0
|
作者
Maurillo, L.
Candoni, A.
Spagnoli, A.
Papayannidis, C.
Borlenghi, E.
Lazzarotto, D.
Fianchi, L.
Sciume, M.
Zannier, M. E.
Buccisano, F.
Riva, M.
Breccia, M.
Fanin, R.
Todisco, E.
Lunghi, M.
De Bellis, E.
Fracchiolla, N.
Musto, P.
Venditti, A.
Rossi, G.
机构
[1] Fdn Policlin Tor Vergata, Dipartimento Oncoematol, Rome, Italy
[2] Univ Roma La Sapienza, Azienda Sanit Univ Integrata, Ematol, Rome, Italy
[3] Asst Spedalicivili, Ist Ematol BL&A Seragnoli, Brescia, Italy
[4] Azienda Sanit Univ Integrata, Ematol, Trieste, Italy
[5] Univ Cattolica Sacro Cuore, Ematol, Milan, Italy
[6] Asst Spedalicivili, Brescia, Italy
[7] Univ Tor Vergata, Dipartimento Biomed & Prevenz, Rome, Italy
[8] Osped Niguarda Ca Granda, Ematol, Milan, Italy
[9] Univ Roma La Sapienza, Ematol, Rome, Italy
[10] Azienda Sanit Univ Integrata, Trieste, Italy
[11] Univ Piemonte Orientale, Div Oncoematol IEO, SCDU Ematol, Vercelli, Italy
[12] Fdn IRCCS Ca Granda Osped Maggiore, UO Oncohematol, Milan, Italy
[13] Univ Tor Vergata, Dipartimento Biomed & Prevenz, IRCCS CROB, Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P078
引用
收藏
页码:89 / 89
页数:1
相关论文
共 50 条
  • [1] Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
    Maurillo, Luca
    Buccisano, Francesco
    Spagnoli, Alessandra
    Voso, Maria Teresa
    Fianchi, Luana
    Papayannidis, Cristina
    Gaidano, Gian Luca
    Breccia, Massimo
    Musto, Pellegrino
    De Bellis, Eleonora
    Del Principe, Maria Ilaria
    Lunghi, Monia
    Lessi, Federica
    Martinelli, Giovanni
    Venditti, Adriano
    ANNALS OF HEMATOLOGY, 2018, 97 (10) : 1767 - 1774
  • [2] Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
    Luca Maurillo
    Francesco Buccisano
    Alessandra Spagnoli
    Maria Teresa Voso
    Luana Fianchi
    Cristina Papayannidis
    Gian Luca Gaidano
    Massimo Breccia
    Pellegrino Musto
    Eleonora De Bellis
    Maria Ilaria Del Principe
    Monia Lunghi
    Federica Lessi
    Giovanni Martinelli
    Adriano Venditti
    Annals of Hematology, 2018, 97 : 1767 - 1774
  • [3] Durable Response with Venetoclax in Combination with Decitabine or Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
    DiNardo, Courtney D.
    Pratz, Keith
    Potluri, Jalaja
    Pullarkat, Vinod
    Jonas, Brian A.
    Wei, Andrew H.
    Becker, Pamela S.
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel A.
    Letai, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S201 - S201
  • [4] Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy
    Maurillo, L.
    Spagnoli, A.
    Candoni, A.
    Papayannidis, C.
    Borlenghi, E.
    Lazzarotto, D.
    Fianchi, L.
    Sciume, M.
    Zannier, M. E.
    Buccisano, F.
    Del Principe, M. I.
    Mancini, V.
    Breccia, M.
    Fanin, R.
    Todisco, E.
    Lunghi, M.
    Palmieri, R.
    Fracchiolla, N.
    Musto, P.
    Rossi, G.
    Venditti, A.
    LEUKEMIA RESEARCH, 2023, 127
  • [5] Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
    DiNardo, Courtney D.
    Pratz, Keith
    Pullarkat, Vinod
    Jonas, Brian A.
    Arellano, Martha
    Becker, Pamela S.
    Frankfurt, Olga
    Konopleva, Marina
    Wei, Andrew H.
    Kantarjian, Hagop M.
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Potluri, Jalaja
    Pollyea, Daniel A.
    Letai, Anthony
    BLOOD, 2019, 133 (01) : 7 - 17
  • [6] Venetoclax with decitabine or azacitidine in the first-line treatment of acute myeloid leukemia
    Bouligny, Ian M.
    Murray, Graeme
    Doyel, Michael
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Wages, Nolan A.
    Grant, Steven
    Maher, Keri R.
    EJHAEM, 2023, 4 (02): : 381 - 392
  • [7] Decitabine in the treatment of acute myeloid leukemia in elderly patients
    Malik, Priya
    Cashen, Amanda F.
    CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 53 - 61
  • [8] A RETROSPECTIVE MULTICENTRE COMPARISON OF INTENSIVE CHEMOTHERAPY WITH AZACITIDINE FOR THE FRONT LINE TREATMENT OF ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
    Maurillo, L.
    Buccisano, F.
    Voso, M. T.
    Fianchi, L.
    Papayannidis, C.
    Gaidano, G. L.
    Breccia, M.
    Musto, R.
    Di Veroli, A.
    Martinelli, G.
    Lunghi, M.
    Lessi, F.
    Del Principe, M. I.
    Ramadan, S. M.
    Suciu, S.
    Amadori, S.
    Venditti, A.
    HAEMATOLOGICA, 2015, 100 : 80 - 81
  • [9] Elderly patient with acute myeloid leukemia refractory to decitabine who responded to treatment with azacitidine
    Galvez, K.
    Combariza, J.
    Gomez, M.
    LEUKEMIA RESEARCH, 2013, 37 : S102 - S102
  • [10] Decitabine in Combination with Venetoclax in Six Elderly Patients with Acute Myeloid Leukemia (AML)
    Rios, Adan
    Kanaan, Zeyad
    Nghia Nguyen
    Rekoff, Gregg
    Chen, Lei
    Wahed, Amer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S211 - S211